NRx Pharmaceuticals (NRXP) Competitors

Invivyd (NASDAQ:IVVD) and NRx Pharmaceuticals (NASDAQ:NRXP) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, community ranking, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

Is IVVD or NRXP more profitable?

NRx Pharmaceuticals' return on equity of 0.00% beat Invivyd's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Invivyd	N/A	-155.33%	-114.88%
NRx Pharmaceuticals	N/A	N/A	-449.16%

Do analysts rate IVVD or NRXP?

Invivyd currently has a consensus target price of $7.89, suggesting a potential upside of 739.72%. NRx Pharmaceuticals has a consensus target price of $31.67, suggesting a potential upside of 1,459.93%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe NRx Pharmaceuticals is more favorable than Invivyd.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Invivyd	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
NRx Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Do insiders and institutionals hold more shares of IVVD or NRXP?

70.4% of Invivyd shares are held by institutional investors. Comparatively, 4.3% of NRx Pharmaceuticals shares are held by institutional investors. 17.9% of Invivyd shares are held by insiders. Comparatively, 19.0% of NRx Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has more risk & volatility, IVVD or NRXP?

Invivyd has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Comparatively, NRx Pharmaceuticals has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Does the MarketBeat Community believe in IVVD or NRXP?

Invivyd received 5 more outperform votes than NRx Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave NRx Pharmaceuticals an outperform vote while only 84.00% of users gave Invivyd an outperform vote.

Company	Underperform	Outperform
Invivyd	Outperform Votes 21 84.00%	Underperform Votes 4 16.00%
NRx Pharmaceuticals	Outperform Votes 16 100.00%	Underperform Votes No Votes

Which has preferable valuation and earnings, IVVD or NRXP?

NRx Pharmaceuticals has lower revenue, but higher earnings than Invivyd. NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than Invivyd, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Invivyd	$11.56M	9.72	-$198.64M	-$1.96	-0.48
NRx Pharmaceuticals	N/A	N/A	-$30.15M	-$2.14	-0.95

Does the media favor IVVD or NRXP?

In the previous week, Invivyd had 6 more articles in the media than NRx Pharmaceuticals. MarketBeat recorded 10 mentions for Invivyd and 4 mentions for NRx Pharmaceuticals. NRx Pharmaceuticals' average media sentiment score of 0.79 beat Invivyd's score of 0.26 indicating that NRx Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Invivyd	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
NRx Pharmaceuticals	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Invivyd and NRx Pharmaceuticals tied by winning 8 of the 16 factors compared between the two stocks.